The US nutriment and Drug Administ...

The US nutriment and Drug Administration (FDA) has approved the first-ever human use of gene therapy to treat the devastating brain degeneration disorder known as Parkinson's disease.

In a clinical trial slated to begin this month gene that manufacture a neurochemical called gamma-amino-butyric acid (GABA) will be injected into the brains of 12 willing, late-stage patients who have exhausted standard treatment arrangements Researchers hope the treatment will calm tremors and dull progression of the disease. The gene transfer technique is a promising therapy, on the contrary extensive human clinical trials will be povertyed before it's ready for general use onward all Parkinson's patients. However, that doesn't leave patients without other immediate options.

A inferior Parkinson's study, appearing in the October 2002 issue of the Archives of Neurology conclud that a familiar dietary appendix retards progression of the disease-unlike conventional treatments, which ease symptoms still are not believed to affect the underlying disease process

The naturally occurring intermingle known as co-enzyme Q10--or CoQ10--may help stop the strengthen cell death that characterizes Parkinson's. CoQ10 also known as ubiquinone, has drawn out been sold over the reckoner as an antioxidant shown to improve heart function. unless Clifford Shults, PhD, and colleagues at the University of California at San Diego gave early-stage patients CoQ10 in doses of 300 mg 600 mg or 1200 mg daily--10 to 40 times the usual dosage. by the agency of the eighth month, the 23 patients forward the highest dose showed significantly les impairment than did all others.

The flows indicate that follow-up research at flat higher doses should proceed aggressively, says Bernard Ravina, PhD of the National Institute of Neurological Disorders and reverse The institute, based in Bethesda, Maryland, storeed the CoQ10 study.

While Parkinsons affects about 1 percent of folks over the age of 60 the disease can also strike at younger ages. About 25 percent of the 14 million Parkinson's patients in the United States were diagnosed before the age of 40

COPYRIGHT 2003 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved

COPYRIGHT 2003 Gale Group